Clinical Trials Browser

Interventional × Colitis, Ulcerative × 1 year × Clear all

NCT03816345 2026-03-18

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT04191655 2026-03-06

High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)

Phase NA Completed

211 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Phase 2 Active not recruiting

42 enrolled

Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

NCT07347158 2026-01-16

Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.

Phase NA Enrolling by invitation

70 enrolled

Gastrointestinal

Anxiety Disorders, Colitis, Ulcerative, Colonic Neoplasms, Depression, Health Education

NCT06881303 2025-11-18

RESTODIG

Phase NA Not yet recruiting

100 enrolled

Gastrointestinal

Colitis, Ulcerative, Crohn Disease, Gastrointestinal Neoplasms, Adenomatous Polyposis Coli

NCT07223424 2025-11-10

PSI-Immune

Phase 2 Recruiting

480 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT06538402 2025-07-09

TESTIMONY

Phase NA Recruiting

120 enrolled

Gastrointestinal

Colitis, Ulcerative, Adenomatous Polyposis Coli

NCT05785715 2025-07-01

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Phase 2 Terminated

81 enrolled

Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular